Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
GST rates unlikely to impact medicine prices as life saving drugs get marked in in low tax basket

The GST tax rates for pharamceuticals does not seem to upset the industry. Question remains, however, as to how smooth the transition will be.

The recently released and long overdue National Health Policy is a welcome move for Indian citizens as the policy aims to ensure health for all by 2030.
Drug firm Divis Laboratories today said the US health regulator has issued a warning letter to the company for its Vishakhapatnam facility.
What should then be made of statements from Cipla about its foray in Brazil and China? Is it only following others into these markets?